当前位置:首页 - 行情中心 - 天康生物(002100) - 财务分析

天康生物

(002100)

  

流通市值:84.78亿  总市值:84.78亿
流通股本:13.65亿   总股本:13.65亿

天康生物(002100)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润1.71亿元,每股收益0.11元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益864982.33万元,未分配利润133458.95万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产1779853.53万元,负债914871.20万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入4,180,253,944.2417,175,805,190.1113,087,153,128.587,993,043,517.91
营业总成本4,012,088,136.816,479,483,378.2112,617,293,868.827,789,522,484.27
营业利润154,716,821.76631,109,922.65587,400,584.34317,343,745.96
利润总额172,533,576.51610,812,435.64571,988,017.46293,797,312.05
净利润171,441,542.03596,421,188.04554,495,769.58279,765,790.58
其他综合收益-41,188,202.22225,776.623,086,398.37-40,712,722.89
综合收益总额130,253,339.81596,646,964.66557,582,167.95239,053,067.69
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计10,244,239,958.979,847,752,197.039,115,407,832.648,897,743,168.88
非流动资产合计7,554,295,360.367,714,760,074.097,806,570,572.287,754,776,746.36
资产总计17,798,535,319.3317,562,512,271.1216,921,978,404.9216,652,519,915.24
流动负债合计6,700,619,328.216,494,865,978.896,162,799,255.86,364,536,497.2
非流动负债合计2,448,092,689.212,548,093,652.42,278,766,530.692,136,949,899.87
负债合计9,148,712,017.429,042,959,631.298,441,565,786.498,501,486,397.07
归属于母公司股东权益合计7,122,587,964.947,015,639,913.056,945,825,951.396,612,173,142.34
股东权益合计8,649,823,301.918,519,552,639.838,480,412,618.438,151,033,518.17
负债和股东权益合计17,798,535,319.3317,562,512,271.1216,921,978,404.9216,652,519,915.24
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计4,135,625,727.3818,713,785,052.9212,780,339,451.087,922,238,137.93
经营活动现金流出小计4,011,581,301.0817,551,919,746.610,634,872,485.637,148,900,307.65
经营活动产生的现金流量净额124,044,426.31,161,865,306.322,145,466,965.45773,337,830.28
投资活动现金流入小计055,443,797.1944,846,026.1421,066,274.9
投资活动现金流出小计72,139,359.2805,462,554.36597,843,758.01533,411,507.31
投资活动产生的现金流量净额-72,139,359.2-750,018,757.17-552,997,731.87-512,345,232.41
筹资活动现金流入小计1,180,253,285.96,863,173,242.43,763,906,836.891,631,983,246.96
筹资活动现金流出小计1,107,466,510.026,994,042,341.074,546,799,823.711,862,277,469.62
筹资活动产生的现金流量净额72,786,775.88-130,869,098.67-782,892,986.82-230,294,222.66
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额124,691,842.98280,977,450.48809,576,246.7630,698,375.21
期末现金及现金等价物余额3,078,254,392.882,953,562,549.93,482,161,346.182,703,283,474.63
最新报告期:2025-05-07
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信证券盛夏,彭家乐0.360.191.172025-05-07
中金公司单妍,王思洋,龙友琪0.330.57--2025-05-01
中国银河谢芝优0.540.680.962025-04-30
开源证券王高展,陈雪丽0.710.681.182025-04-30
财通证券肖珮菁0.530.550.762025-04-30
TOP↑